↓ Skip to main content

Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy

Overview of attention for article published in Cochrane database of systematic reviews, December 2014
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (72nd percentile)

Mentioned by

twitter
1 tweeter
wikipedia
1 Wikipedia page

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
16 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy
Published in
Cochrane database of systematic reviews, December 2014
DOI 10.1002/14651858.cd007124.pub4
Pubmed ID
Authors

Powell G, Saunders M, Rigby A, Marson AG, Powell, Graham, Saunders, Matthew, Rigby, Alexandra, Marson, Anthony G

Abstract

Epilepsy is defined as the tendency to spontaneous, excessive neuronal discharge manifesting as seizures. It is a common disorder with an incidence of 50 per 100,000 per year and a prevalence of 0.5% to 1% in the developed world (Hauser 1993).Carbamazepine (CBZ) is a widely used antiepileptic drug that is associated with a number of troublesome adverse events including dizziness, double vision and unsteadiness. These often occur during peaks in drug plasma concentration. The occurrence of such adverse events may limit the daily dose that can be tolerated and reduce the chances of seizure control for patients requiring higher doses (Vojvodic 2002). A controlled-release formulation of carbamazepine delivers the same dose over a longer period of time when compared to a standard formulation, thereby reducing post-dose peaks and potentially reducing adverse events associated with peak plasma levels.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 16 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 6%
Unknown 15 94%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 5 31%
Researcher 3 19%
Student > Master 3 19%
Other 1 6%
Professor 1 6%
Other 3 19%
Readers by discipline Count As %
Medicine and Dentistry 9 56%
Psychology 3 19%
Pharmacology, Toxicology and Pharmaceutical Science 2 13%
Agricultural and Biological Sciences 1 6%
Engineering 1 6%
Other 0 0%

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 May 2017.
All research outputs
#2,453,174
of 9,782,970 outputs
Outputs from Cochrane database of systematic reviews
#5,799
of 8,982 outputs
Outputs of similar age
#66,894
of 248,759 outputs
Outputs of similar age from Cochrane database of systematic reviews
#184
of 252 outputs
Altmetric has tracked 9,782,970 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 8,982 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.1. This one is in the 34th percentile – i.e., 34% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 248,759 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 252 others from the same source and published within six weeks on either side of this one. This one is in the 26th percentile – i.e., 26% of its contemporaries scored the same or lower than it.